How should we react to adverse drug reactions?

被引：0

作者：

Ferner, R. E. ^{[1
]}

Beard, K. ^{[1
]}

机构：

[1] City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England

来源：

POSTGRADUATE MEDICAL JOURNAL | 2011年 / 87卷 / 1024期

关键词：

CARDIOVASCULAR EVENTS; ROFECOXIB; RISK;

D O I：

10.1136/pgmj.2010.105064

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：81 / 82

页数：2

共 11 条

[1] A comparative analysis of drug safety withdrawals in the UK and the US (1971-1992): Implications for current regulatory thinking and policy
Abraham, J
Davis, C
[J]. SOCIAL SCIENCE & MEDICINE, 2005, 61 (05) : 881 - 892
[2] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
Bombardier, C
Laine, L
Reicin, A
Shapiro, D
Burgos-Vargas, R
Davis, B
Day, R
Ferraz, MB
Hawkey, CJ
Hochberg, MC
Kvien, TK
Schnitzer, TJ
Weaver, A
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) : 1520 - 1528
[3] Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
Bresalier, RS
Sandler, RS
Quan, H
Bolognese, JA
Oxenius, B
Horgan, K
Lines, C
Riddell, R
Morton, D
Lanas, A
Konstam, MA
Baron, JA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) : 1092 - 1102
[4] Claire B, 2000, N Engl J Med, V343, P1520, DOI [DOI 10.1056/NEJME058314, 10.1056/NEJMe058314.73, DOI 10.1056/NEJM200011233432103, 10.1056/NEJM200011233432103]
[5] Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000;343:1520-8
Curfman, GD
Morrissey, S
Drazen, JM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (26) : 2813 - 2814
[6] PROBABILITY OF ADVERSE EVENTS THAT HAVE NOT YET OCCURRED - A STATISTICAL REMINDER
EYPASCH, E
LEFERING, R
KUM, CK
TROIDL, H
[J]. BRITISH MEDICAL JOURNAL, 1995, 311 (7005) : 619 - 620
[7] Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs
Graham, DJ
Staffa, JA
Shatin, D
Andrade, SE
Schech, SD
La Grenade, L
Gurwitz, JH
Chan, KA
Goodman, MJ
Platt, R
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (21): : 2585 - 2590
[8] Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
Juni, P
Nartey, L
Reichenbach, S
Sterchi, R
Dieppe, PA
Egger, M
[J]. LANCET, 2004, 364 (9450) : 2021 - 2029
[9] Licensing drugs for diabetes
Lehman, Richard
Yudkin, John S.
Krumholz, Harlan
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2010, 341
[10] Rosiglitazone Revisited An Updated Meta-analysis of Risk for Myocardial Infarction and Cardiovascular Mortality
Nissen, Steven E.
Wolski, Kathy
[J]. ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (14) : 1191 - 1201

← 1 2 →